Business Description
Devyser Diagnostics AB
ISIN : SE0016588867
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.15 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -2.48 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.45 | |||||
Beneish M-Score | -1.87 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.3 | |||||
3-Year EPS without NRI Growth Rate | -52.7 | |||||
3-Year FCF Growth Rate | -193.5 | |||||
3-Year Book Growth Rate | 108.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 36.39 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.73 | |||||
9-Day RSI | 56.04 | |||||
14-Day RSI | 54.3 | |||||
6-1 Month Momentum % | 40.41 | |||||
12-1 Month Momentum % | 28.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.71 | |||||
Quick Ratio | 4.34 | |||||
Cash Ratio | 3.31 | |||||
Days Inventory | 228.26 | |||||
Days Sales Outstanding | 71.91 | |||||
Days Payable | 178 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.3 | |||||
Shareholder Yield % | -3.55 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.71 | |||||
Operating Margin % | -27.48 | |||||
Net Margin % | -25.43 | |||||
FCF Margin % | -66.37 | |||||
ROE % | -11.65 | |||||
ROA % | -9.02 | |||||
ROIC % | -23.45 | |||||
ROC (Joel Greenblatt) % | -48.09 | |||||
ROCE % | -9.89 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.72 | |||||
PB Ratio | 4.46 | |||||
Price-to-Tangible-Book | 5.41 | |||||
EV-to-EBIT | -34.21 | |||||
EV-to-Forward-EBIT | -131.04 | |||||
EV-to-EBITDA | -55.36 | |||||
EV-to-Forward-EBITDA | 436.81 | |||||
EV-to-Revenue | 8.43 | |||||
EV-to-Forward-Revenue | 5.42 | |||||
EV-to-FCF | -12.71 | |||||
Price-to-Net-Current-Asset-Value | 9.08 | |||||
Price-to-Net-Cash | 17.98 | |||||
Earnings Yield (Greenblatt) % | -2.92 | |||||
FCF Yield % | -7.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Devyser Diagnostics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 180.5 | ||
EPS (TTM) (kr) | -2.82 | ||
Beta | 0 | ||
Volatility % | 33.03 | ||
14-Day RSI | 54.3 | ||
14-Day ATR (kr) | 3.49439 | ||
20-Day SMA (kr) | 100.32 | ||
12-1 Month Momentum % | 28.13 | ||
52-Week Range (kr) | 57.4 - 109 | ||
Shares Outstanding (Mil) | 16.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Devyser Diagnostics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Devyser Diagnostics AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Devyser Diagnostics AB Frequently Asked Questions
What is Devyser Diagnostics AB(OSTO:DVYSR)'s stock price today?
When is next earnings date of Devyser Diagnostics AB(OSTO:DVYSR)?
Does Devyser Diagnostics AB(OSTO:DVYSR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |